AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

172.310

+0.7400.43%

Volume:1.50M

Turnover:259.17M

Market Cap:82.52B

PE:-23.02

High:175.365

Open:172.800

Low:171.000

Close:171.570

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.27

T/O Rate:0.31%

Dividend:4.12

Dividend Rate:2.39%

EPS(TTM):-7.487

EPS(LYR):-7.488

ROE:-15.83%

ROA:7.26%

PB:3.98

PE(LYR):-23.01

Loading ...

Overview Company News Filings

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

CSL's U.S. Agreements Remove Two Stock Overhangs

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS

CSL’s latest result suggests the worst may be over

Morning Star AU

Is CSL (ASX:CSL) Cheap On Results, 2027 Guidance And Its Dividend?

Simply Wall St.

CSL (ASX:CSL) Is Up 24.5% After Posting a Net Loss but Guiding for NPAT Growth - What's Changed

Simply Wall St.

Carlisle Companies (CSL) Dividend Hike Puts Its Undervalued Narrative In Focus

Simply Wall St.

Weekly earnings wrap: BHP, CSL, NAB and more

Morning Star AU

ASX healthcare giant rallies despite a fall in profits

Morning Star AU

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":172.31,"timestamp":1788243120000,"preClose":171.57,"halted":0,"volume":1501636,"delay":0,"changeRate":0.004313108352276092,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.487984234644033,"marketStatus":"Closed","change":0.74,"latestTime":"09-01 16:12:00 AEST","open":172.8,"high":175.365,"low":171,"amount":259171238,"amplitude":0.025442,"askPrice":172.31,"askSize":5,"bidPrice":172.2,"bidSize":250,"shortable":3,"etf":0,"ttmEps":-7.487984234644033,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":171.57,"dividendRate":0.023897,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":1.265648,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.57,"auctionPrice":172.33,"auctionVolume":317793,"auctionTime":1788243005735,"referencePrice":172.31,"referenceTime":1788258603092,"auction":3,"marketStatus":"盘后竞价","timestamp":1788243005735}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.487984,"volumeRatio":1.265648,"shares":478911979,"dividePrice":4.1177,"high":175.365,"amplitude":0.025442,"preClose":171.57,"low":171,"week52Low":90,"pbRate":"3.98","psRate":"3.73","week52High":219.589,"institutionHeld":0,"latestPrice":172.31,"committee":0.960784,"eps":-7.486747756774457,"divideRate":0.023897,"volume":1501636,"delay":0,"ttmEps":-7.486747756774457,"open":172.8,"prevYearClose":170.408,"prevWeekClose":172.32,"prevMonthClose":171.57,"prevQuarterClose":114.74,"fiveDayClose":173.64,"twentyDayClose":128.83,"sixtyDayClose":99.47,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU0553294199.USD","LU0820561909.HKD","IE00BSNM7G36.USD","LU0096364046.USD","LU1883839398.USD","LU0154236417.USD","LU0471298694.HKD","LU0225284248.USD","LU0225283273.USD","LU1059921491.USD","OZEM","LU0234570918.USD","LU0310800379.SGD","LU2750360641.GBP","SG9999014567.USD","LU2133065610.SGD","LU1699723380.USD","LU0345770308.USD","LU0980610538.SGD","LU0029864427.USD","LU1989771016.USD","BK4533","BK4592","LU1934455194.USD","IE0001KFT4U8.USD","LU0861579265.USD","LU1691799644.USD","LU0198837287.USD","LU0058720904.USD","LU0787776722.HKD","IE000F7OJYX1.SGD","LU2028103732.USD","LU2361045086.USD","LU1032955483.USD","LU0130517989.USD","LU0210528500.USD","LU0985320562.USD","PFE","FTXH","LU2023250330.USD","LU2271345857.HKD","LU0965509101.SGD","LU0889565916.HKD","LU0225771236.USD","LU2168564222.USD","IE0034235303.USD","LU1674673428.USD","SG9999015986.USD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU0726765562.USD","LU0109394709.USD","LU1718418525.SGD","LU2505996681.GBP","IE00BVYPNV92.GBP","LU1894683348.USD","ELIS","SG9999018857.SGD","SGXZ31699556.SGD","IE00BN8TJ469.HKD","IE00BFXG1179.USD","IE0004445015.USD","IXJ","LU0320765646.SGD","LU1236620750.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","IE0002270589.USD","LU0053666078.USD","LU0323591593.USD","LU0266013472.USD","AZNH","IBBQ","LU1548497426.USD","LU0320765489.SGD","GB00BDT5M118.USD","LU0661504455.SGD","LU1829250122.USD","LU0124676726.USD","LU1974910355.USD","BK7067","NVOH","LU2125154778.USD","LU1162221912.USD","LU0466842654.USD","SG9999014906.USD","LU2491049909.HKD","LU1585245621.USD","SG9999015341.SGD","LU2746668974.SGD","IE00B4JS1V06.HKD","LLYX","SG9999017495.SGD","GDOC","JDOC","SG9999002232.USD","SG9999014559.SGD","LU0994945656.USD","SG9999015945.SGD","IE000WAW04H5.SGD","IE00BFTCPJ56.SGD","LU1221951046.USD","LU1670711123.USD","LU1868836757.USD","LU1366192091.USD","LU2896262040.SGD","LU1988902786.USD","LU1868836914.USD","LU2089283258.USD","LU2089284900.SGD","BK4585","LU1934455277.USD","IE00B775H168.HKD","LU1280957306.USD","LU1244550494.USD","IE000BZT7R73.USD","LU0795875169.SGD","LU1629891620.HKD","SG9999002224.SGD","LU0345770993.USD","LU0511384066.AUD","LU0882574055.USD","LU1057294990.SGD","LU1116320901.HKD","LU2552382058.USD","JNJ","LU2087625088.SGD","LU0683600562.USD","LU0648001328.SGD","LU2125909593.SGD","LU2089984988.USD","LU1571399168.USD","BIB","LLY","IE00BVYPNW00.USD","LU0395794307.EUR","IE00B2B36J28.USD","LU2750360997.AUD","RXL","LU0256863902.USD","LU0006306889.USD","LU1267930813.SGD","LU0820562030.AUD","LU0289739343.SGD","LU1923622614.USD","LU2468319806.SGD","LU0321505868.SGD","LU0267386448.USD","LU0321505439.SGD","LU1868837136.USD","LU2242652126.USD","IE000MB6IJN5.SGD","LU2168564495.EUR","LU0265550946.USD","LU0061475181.USD","LU0965508806.USD","04332","BK4578","LU1069344957.HKD","LU1236620834.HKD","LU2746668461.USD","IE00B19Z3581.USD","LLYZ","LU2237443622.USD","LU0417517546.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0170899867.USD","IE00BBT3K403.USD","LU2487616109.SGD","LU1670710661.SGD","ELIL","LU1934455863.HKD","IE00BJJMRX11.SGD","LU2461242641.AUD","LU0432979614.USD","LU1551013425.SGD","LU0965509010.AUD","AMGN","LU0265550359.USD","SGXZ81514606.USD","IE000M9KFDE8.USD","IE0009355771.USD","LU0162691827.USD","LU1066051225.USD","REGN","IE00BJLML261.HKD","BBIO","LU2347655156.SGD","BK4550","ABBV","LU0316494557.USD","NVOX","SG9999014914.USD","LU2129689605.HKD","LU0859254822.USD","LU1023059063.AUD","LU1670711040.USD","LU1670628061.USD","LU1074936037.SGD","LU2471134796.USD","LU1127390331.HKD","IE000SO60NU8.SGD","SG9999013999.USD","LU2023251221.USD","IE00BDGV0183.EUR","LU1804176565.USD","LU1228905540.USD","GLAM","LU2347655073.USD","LU1116320737.USD","SG9999014575.USD","LU2602419157.SGD","LU1003077747.HKD","LU2756315318.SGD","AZN","LU2063271972.USD","IE00BN29S564.USD","LU0211327993.USD","NVS","LU1929549753.HKD","LU1267930730.SGD","IE00B19Z3B42.SGD","IE00BJJMRY28.SGD","LU0238689110.USD","LU0689472784.USD","IE00BLSP4452.SGD","LU1623119135.USD","LU0098860793.USD","LU0882574139.USD","LU1868837300.USD","VHT","LU1093756325.SGD","LU1935042991.SGD","PAWZ","LU1043141396.HKD","LU0097036916.USD","SGXZ57979304.SGD","LU2596442595.SGD","LU1066051811.HKD","LU0545562505.USD","LU1032466523.USD","LU1732799900.SGD","LU1989772923.USD","SG9999014542.SGD","LU0385154629.USD","CSL.AU","LU0109391861.USD","BK4568","LU0545039389.USD","LU0094547139.USD","AGNG","LU0345769631.USD","LU0472753341.HKD","LU0203345920.USD","LU0456855351.SGD","IE0002141913.USD","LU0203201768.USD","BK4007","LU2462157665.USD","LU1989772840.SGD","BK4566","LU2430703178.SGD","IE00BK4W5L77.USD","BK4588","LU1221951129.SGD","BMY","MEDX","LU0943347566.SGD","LU0203202063.USD","LU1551013342.USD","06160","GSK","IE00BKVL7J92.USD","LU1983299246.USD","PJP","LU0345769128.USD","LU1430594728.SGD","688235","GSKH","BK4504","BK4581","LU1061106388.HKD","LU0106261372.USD","LU0868494617.USD","LU2361044865.SGD","LU0211331839.USD","LU0426417589.USD","SG9999015978.USD","SGXZ99366536.SGD","LU0289961442.SGD","LU0203347892.USD","LU2552382215.SGD","LU2471134879.HKD","LU0237698245.USD","LU0158827948.USD","LU2236285917.USD","LU0320765992.SGD","LU2756315664.SGD","LU1066053197.SGD","LU2125909247.SGD","NVO","LU1201861249.SGD","LU0792757196.USD","LU0353189763.USD","LU0310799852.SGD","LU2430703095.HKD","LU2108987350.USD","LU2237443382.USD","LU1323610961.USD","LU1712237335.SGD","LU2552382132.HKD","GILD","LU1066051498.USD","LU2211815571.USD","LU0640476718.USD","LU0354030438.USD","SG9999003800.SGD","IE00BWXC8680.SGD","LU0306806265.USD","SGXZ80539844.SGD","LU2491050154.USD","MHIP","ONC","LU2242646821.SGD","LU2087621335.USD","SG9999001440.SGD","LU1670710588.SGD","LU1979441026.SGD","LU0985481810.HKD","IE00B4R5TH58.HKD","MEDI","BK4534","LU1196500208.SGD","LU2168563687.JPY","THNR","TBXU","IE00B1XK9C88.USD","LU0738911758.USD","LU0889566641.SGD","IE00BGHQF631.EUR","IE00B7SZLL34.SGD","LU2360032135.SGD","IE00BFSS8Q28.SGD","BK7511","LU0234572021.USD","LU2237438978.USD","LU1670627923.USD","LU0795875086.SGD","LU0128525929.USD","LU2168564065.EUR","SG9999011175.SGD","CANC","IE00BKDWB100.SGD","BBH","LU2433249047.HKD","LU0256863811.USD","LU2264538146.SGD","LU1035775433.USD","LU2125154935.USD","BK0239","LU0070217475.USD","LU1035773651.USD","LU1244550221.USD","LU2462591350.SGD","LU0823416689.USD","IE00B42XCP33.USD","LU1496350171.SGD","LU2403377893.USD","IE0005OL40V9.USD","LU0965509283.SGD","LU1069347547.HKD","LU0057025933.USD","HRTS","LU1267930573.SGD","SG9999001176.USD","BK4516","LU0158827781.USD","LLII","IE00B3T34201.USD","LU2237443895.HKD","LU0708994859.HKD","LU0289739699.SGD","BK4559","LU0672654240.SGD","LU1244550577.SGD","LU1291159041.SGD","IBB","XLV","BK4532","LU0070302665.USD","LU0211328371.USD","LU0320765059.SGD","FHLC","IE00BFSS7M15.SGD","LU1261432733.SGD","BK4599","LU2129689514.USD","SG9999001176.SGD","LU1093756168.USD","LU0823434583.USD","LU0868494708.USD","LU2237443978.SGD","LU0174119429.USD","GSK.UK","LU1064131342.USD","LU1732800096.USD","LU0823434740.USD","SGXZ51526630.SGD","LU1917777945.USD","LU0072461881.USD","LU0942090050.USD","WDNA","LU1267930490.SGD","LU2213496289.HKD","MRK","LU1941712264.USD","LU0133085943.USD","CURE","LU2111349929.HKD","SG9999014880.SGD","LU2417539215.USD","BK4583","LU0306807586.USD","LU0786609619.USD","SG9999014898.SGD","LU1496350502.SGD","LU0130102774.USD","LU2471134952.CNY","LU1121112475.USD","LU2592432038.USD","LU2265009873.SGD","LU0210536198.USD","LU1720051017.SGD","LU1232071149.USD","LU2471134523.USD","LU0689626769.HKD","LU1868836591.USD","LU2129689431.USD","LU1814569148.SGD","LU2237443549.SGD","IE0000B7K699.USD","BMED","ILDR","LU1037948897.HKD","PBE","LU2023250504.SGD","LU2324357040.USD","LU2237443465.HKD","LU1941712348.USD","LU0964807845.USD","SG9999015952.SGD","LU2357305700.SGD","LU1839511570.USD","LU0949170772.SGD","TRUH","LU0114720955.EUR","LU2360106947.USD","BK7501","IE00BJJMRZ35.SGD","IE0004445239.USD","LU0912757837.SGD","LU2362541273.HKD","LU0069063385.USD","LU1778281490.HKD","LU0353189680.USD","LU1674673691.USD","LU2430703251.USD","IE00BJT1NW94.SGD","LU2362540622.SGD","IE00B1BXHZ80.USD","LU2456880835.USD","SG9999018865.SGD","LU0208291251.USD","LU1506573853.SGD","BK4139","LU1720051108.HKD","IE00BKPKM429.USD","LU0122379950.USD","IE00B3PB1722.GBP","LU2505996509.AUD","TMED","IE00BLSP4239.USD","IYH","LU1228905037.USD","LU0079474960.USD","LU0471298777.SGD","LU0820561818.USD","IE00B7KXQ091.USD","LU2357627491.SGD","LU1894683264.USD","LU0354030511.USD","BK4505","LU1145028129.USD","LU2361044949.HKD","LU2362541513.USD","LU2168564149.EUR","LU1043141123.HKD","LU2491050071.SGD","LU1914381329.SGD","NVOC","IHE","BK7508","PPH","LU2023250843.SGD","LU0426412945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887889","title":"CSL's U.S. Agreements Remove Two Stock Overhangs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887889","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887889?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:22","pubTimestamp":1788229320,"startTime":"0","endTime":"0","summary":"0222 GMT - CSL's U.S. agreements on drug pricing and manufacturing expansion remove two overhangs on the stock, Morgans analyst Derek Jellinek says. He tells clients in a note that the Australia-based pharmaceutical company has reinforced its competitive position as a major U.S. manufacturer of plasma-derived therapies. Jellinek sees the key positive of CSL's Medicaid pricing agreement as the improved visibility on exposure to potential U.S. drug-pricing reform. As for its onshoring agreement, he reckons it gives greater certainty with regard to tariff exposure. Morgans has a last-published buy rating on the stock and a target price of 187.71 Australian dollars. Shares are up 0.9% at A$173.07.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7508","CSL.AU","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899648","title":"ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899648","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899648?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:12","pubTimestamp":1788221579,"startTime":"0","endTime":"0","summary":"Australian shares are poised to fall on Tuesday as oil prices surged more than 2.5% after renewed US-Iran military action heightened concerns over global supply disruptions and a prolonged conflict.Ov","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QFN.AU","BK7511","IISV.AU","BEAR.AU","BK7067","QRE.AU","BK7501","BK7104","IIGF.AU","E200.AU","VAP.AU","GEAR.AU","STW.AU","EIGA.AU","SLF.AU","IMLC.AU","CSL.AU","BK7508","BBOZ.AU","IOZ.AU","XJO.AU","XKO.AU","OZR.AU","XAO.AU","VAS.AU","AUC.AU","DACE.AU","ZYAU.AU","OZF.AU","GIVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886424","title":"CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886424","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886424?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:29","pubTimestamp":1788218965,"startTime":"0","endTime":"0","summary":"CSL  has entered agreements with the US Administration to lower medicine costs and expand its manufacturing footprint in the US, according to a Tuesday Australian bourse filing.The company will provide Medicaid access to its medicines at prices comparable to those in other developed countries and extend similar pricing to newly launched therapies for all US payers under an agreement with the US Department of Health and Human Services, per the filing.The company has also entered into an onshoring agreement with the US Department of Commerce for its planned $1.5 billion expansion in Kankakee, Illinois, aimed at increasing production of plasma-derived therapies, the filing said.The company said the agreements are not expected to materially affect fiscal 2027 financial results, while providing greater certainty over US drug pricing and potential Section 232 tariff exposure, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","CSL.AU","BK7508","BK7067","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033885","title":"CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033885","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:28","pubTimestamp":1788215330,"startTime":"0","endTime":"0","summary":"CSL signs U.S. government agreements to lower drug prices for MedicaidCSL signed agreements with the US government to lower US drug prices, including Medicaid pricing comparable to other developed cou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbfGxJ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7508","BK7067","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852458","title":"CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664852458?lang=en_us&edition=fundamental","pubTime":"2026-09-01 06:17","pubTimestamp":1788214638,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE3CPQVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU1983299246.USD","LU1057294990.SGD","BK0046","BK4550","300485","IE00BLSP4239.USD","LU2112291526.USD","SG9999002224.SGD","CSL.AU","BK4505","BK4534","LU0109394709.USD","IE00B3T34201.USD","BIB","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK0028","BBIO","IBBQ","BK4566","LU0320765992.SGD","688235","TBXU","BBH","PFE","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4007","OZEM","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PJP","AMGN","IE0002270589.USD","LU0225284248.USD","LU0889565916.HKD","IE0002141913.USD","LU0306806265.USD","SGXZ57979304.SGD","PBE","IBB","LU0321505439.SGD","BK7511","SG9999001176.SGD","LU2468319806.SGD","IONS","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664701000","title":"CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois","url":"https://stock-news.laohu8.com/highlight/detail?id=2664701000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664701000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664400070","title":"CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664400070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664400070?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7508","BK7067","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664082000","title":"CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664082000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664082000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7501","BK7508","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007000","title":"CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007000?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7508","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000920","title":"CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000920?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7508","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000707","title":"CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000707?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000088","title":"CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000088?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:22","pubTimestamp":1788204143,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0J9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","CSL.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800678","title":"CSL’s latest result suggests the worst may be over","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800678","media":"Morning Star AU","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800678?lang=en_us&edition=fundamental","pubTime":"2026-08-31 00:00","pubTimestamp":1788105600,"startTime":"0","endTime":"0","summary":"CSL’s (ASX:CSL) earnings result was not particularly impressive on the surface. Underlying earnings fell 2%, while a USD 7.1 billion impairment charge pushed statutory earnings into the red. Despite t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/csls-latest-result-suggests-worst-may-be-over","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/csls-latest-result-suggests-worst-may-be-over","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["GXDW","RGLO","BK7501","BK7511","PMDE","FEBU","DECU","BK7067","CSL.AU","CDIG","BK7508","VGFPF","JOYT","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662032654","title":"Is CSL (ASX:CSL) Cheap On Results, 2027 Guidance And Its Dividend?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662032654","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662032654?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:21","pubTimestamp":1787865674,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is in focus after releasing its full year 2026 results, issuing earnings guidance for 2027, and declaring a US$1.62 per share dividend. This combination gives investors several fresh data points to assess.\nThe CSL share price has reacted sharply around these results, with a 30 day share price return of 45.48% and a 90 day share price return of 79.98% taking it to A$173.88, even though the 1 year total shareholder return is still down 16.24% and the 5 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-results-2027-guidance-and-its-dividen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-results-2027-guidance-and-its-dividen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661925792","title":"CSL (ASX:CSL) Is Up 24.5% After Posting a Net Loss but Guiding for NPAT Growth - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2661925792","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661925792?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:28","pubTimestamp":1787279328,"startTime":"0","endTime":"0","summary":"In August 2026, CSL Limited reported full-year results showing revenue rising slightly to US$15.80 billion but moving from prior net income to a US$2.58 billion net loss, while also declaring a US$1.62 per share dividend for the six months ended June 30, 2026, payable on October 2, 2026.\nAt the same time, CSL issued 2027 guidance calling for revenue to remain in line with the prior year but underlying NPAT to increase by about 5%, highlighting a contrast between current headline losses and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-up-245-after-posting-a-net-loss-but-guiding-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-is-up-245-after-posting-a-net-loss-but-guiding-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VTHR","BK7501","BK7067","ARTY","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7511","LU0728928796.USD","BK7508","BK4086","CHAT","CSL","CSL.AU","QTOC","AIPO","AGIX","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660155477","title":"Carlisle Companies (CSL) Dividend Hike Puts Its Undervalued Narrative In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2660155477","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660155477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:38","pubTimestamp":1787189919,"startTime":"0","endTime":"0","summary":"Dividend increase draws attention to Carlisle Companies stock\nCarlisle Companies (CSL) has drawn investor focus after its board approved a 14% increase in the regular quarterly dividend to $1.25 per share, payable on September 1, 2026.\nSee our latest analysis for Carlisle Companies.\nCarlisle Companies’ dividend move comes after a period where the share price has shown positive momentum in recent months, with an 11.7% 1 month share price return and a 10.0% 3 month share price return, while the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-dividend-hike-puts-its-undervalued-na","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-dividend-hike-puts-its-undervalued-na","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4086","BK7501","LU1169590202.USD","BK7508","LU0728928796.USD","BK7511","BK7067","SGXZ23171101.USD","CSL","CSL.AU","SG9999004303.SGD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661254530","title":"Weekly earnings wrap: BHP, CSL, NAB and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2661254530","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661254530?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:00","pubTimestamp":1787155200,"startTime":"0","endTime":"0","summary":"This is the third edition of our weekly wrap for the August 2026 earnings season. Earnings is now in full swing with some of the largest names on the ASX reporting this week. BHP reported strongly on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-bhp-csl-nab-more","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/weekly-earnings-wrap-bhp-csl-nab-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["DECU","BHP.AU","BHP","JOYT","RGLO","CSL","PMDE","VOTE","GXDW","CSL.AU","VGFPF","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660470729","title":"ASX healthcare giant rallies despite a fall in profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2660470729","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660470729?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:00","pubTimestamp":1787155200,"startTime":"0","endTime":"0","summary":"CSL’s (ASX.CSL) fiscal 2026 underlying earnings fell 2%, in line with the guidance reset in May, and USD 7.1 billion of impairments drove a statutory loss. Fiscal 2027 guidance is for flat revenue and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-healthcare-giant-rallies-despite-fall-profits","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-healthcare-giant-rallies-despite-fall-profits","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["VHT","BK7501","CGCV","TCAF","BK4585","BK4550","IXJ","NOBL","BK7067","CSL.AU","BK7511","BK4588","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}